تداخل‌های دارویی
Natalizumab + Ublituximab
شدت: شدید
Natalizumab and Ublituximab: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Natalizumab limits immune cell entry into tissues including the CNS, and ublituximab depletes B cells. Together they may increase the risk of serious infections, including progressive multifocal leukoencephalopathy.
معنای این تداخل به زبان ساده
Natalizumab and Ublituximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Natalizumab belongs to Gastrointestinal Tract; Ublituximab belongs to Miscellaneous.
چرا رخ می‌دهد
Additive immunosuppression through blocked leukocyte trafficking plus CD20 B-cell depletion.
اقدام لازم
Avoid concurrent use. When switching, plan the washout using the effect duration of the first agent, and monitor for infection and new neurological symptoms.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Natalizumab و Ublituximab، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Natalizumab
تداخلات دیگر Ublituximab
پرسش‌های متداول
Can I take Natalizumab with Ublituximab?
MediHelp rates the interaction as major. Natalizumab and Ublituximab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Natalizumab limits immune cell entry into tissues including the CNS, and ublituximab depletes B cells. Together they may increase the risk of serious infections, including progressive multifocal leukoencephalopathy.
How serious is the interaction between Natalizumab and Ublituximab?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use. When switching, plan the washout using the effect duration of the first agent, and monitor for infection and new neurological symptoms.
What other medicines interact with Natalizumab?
MediHelp also lists interactions of Natalizumab with, for example, Vedolizumab, Axicabtagene ciloleucel, Baricitinib. The full list is on the Natalizumab page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
